Xenetic Biosciences, Inc. (XBIO)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
As of 10:21AM EDT. Market open.
| Previous close | 3.7700 |
| Open | 3.9901 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's range | 3.9901 - 4.1299 |
| 52-week range | 2.5500 - 5.9700 |
| Volume | |
| Avg. volume | 5,772 |
| Market cap | 6.363M |
| Beta (5Y monthly) | 2.67 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -2.7100 |
| Earnings date | 09 May 2024 - 13 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Simply Wall St.Xenetic Biosciences Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag
Xenetic Biosciences ( NASDAQ:XBIO ) Full Year 2023 Results Key Financial Results Revenue: US$2.54m (up 49% from FY...
Simply Wall St.Most Shareholders Will Probably Agree With Xenetic Biosciences, Inc.'s (NASDAQ:XBIO) CEO Compensation
Key Insights Xenetic Biosciences will host its Annual General Meeting on 6th of December Total pay for CEO Jeff...
ZacksXenetic Biosciences (XBIO) Reports Q2 Loss, Tops Revenue Estimates
Xenetic Biosciences (XBIO) delivered earnings and revenue surprises of 38.94% and 47.96%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
© 2024 Yahoo. All rights reserved.